CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $795
- in 4 filings, $795 under 10b5-1 plans
Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-26 | Aunins John G. Chief Technology Officer & EVP | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2017-01-26 | Aunins John G. Chief Technology Officer & EVP | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2017-01-26 | Hashad Wael EVP & Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2017-01-26 | Hashad Wael EVP & Chief Commercial Officer | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2017-01-26 | Shaff Eric D. CFO and EVP | Grant or award · Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2017-01-26 | Shaff Eric D. CFO and EVP | Grant or award · Restricted Stock Units | +40,000 | 40,000 | ||
| 2017-01-26 | Trucksis Michele Chief Medical Officer and EVP | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2017-01-26 | Trucksis Michele Chief Medical Officer and EVP | Grant or award · Restricted Stock Units | +37,500 | 37,500 | ||
| 2017-01-26 | Pomerantz Roger President and CEO | Grant or award · Stock Option (right to buy) | +261,000 | 261,000 | ||
| 2017-01-26 | COOK DAVID N Chief Scientific Officer & EVP | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2017-01-26 | COOK DAVID N Chief Scientific Officer & EVP | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2016-09-19 | Aunins John G. Chief Technology Officer & EVP | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2016-08-29 | Aunins John G. Chief Technology Officer & EVP | Sale | −9,390 | $10.87 | $102K | 192,125 |
| 2016-07-28 | Trucksis Michele Chief Medical Officer and EVP | Exercise or conversion | +4,156 | $15.77 | $66K | 4,156 |
| 2016-07-28 | Trucksis Michele Chief Medical Officer and EVP | Sale | −4,156 | $35.18 | $146K | 0 |
| 2016-07-28 | Trucksis Michele Chief Medical Officer and EVP | Exercise or conversion · Stock Option (Right to Buy) | +4,156 | 296,904 | ||
| 2016-07-27 | Aunins John G. Chief Technology Officer & EVP | Sale | −9,250 | $35.00 | $324K | 201,515 |
| 2016-07-27 | Pomerantz Roger President and CEO | Exercise or conversion | +20,000 | $0.71 | $14K | 203,692 |
| 2016-07-27 | Pomerantz Roger President and CEO | Sale | −20,000 | $35.00 | $700K | 183,692 |
| 2016-07-27 | Pomerantz Roger President and CEO | Exercise or conversion · Stock Option (right to buy) | −20,000 | 1,052,286 |
Page 31 of 34 · 662 trades